New RNA test could predict breast cancer treatment success early

NCT ID NCT03524430

Recruiting now Knowledge-focused Sponsor: Rna Diagnostics Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 34 times

Summary

This study is testing a new RNA test (called RDA) to see how well breast cancer responds to chemotherapy before surgery. About 800 women with early-stage breast cancer will give a small tumor sample about 5 weeks after starting chemo. The goal is to see if the test can accurately predict whether the cancer is completely gone by the time of surgery, which could help doctors personalize treatment in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM FEMALE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital U. 12 de Octubre
RECRUITING

Madrid, Spain
Institut de Cancerologie de Strasbourg
RECRUITING

Strasbourg, France
NZOZ Neuromed
RECRUITING

Lublin, Poland
SST di Cremona Multidisciplinare di Patologia Mammaria, Italy
RECRUITING

Cremona, Italy
Siteman Cancer Center
RECRUITING

St Louis, Missouri, 63129, United States
Sunnybrook Health Sciences Center
RECRUITING

Toronto, Canada
Universitätsklinikum Münster
RECRUITING

Münster, Germany

Conditions

Explore the condition pages connected to this study.

BREAST NEOPLASM FEMALE BREAST NEOPLASM FEMALE